Note: Ingredients listed on restricted chemical lists
EC/CAS
229-352-5/6485-40-1
Name of the chemical
2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one;(5R)-2-Methyl-5-prop-1-en-2-ylcyclohex-2-en-1-one;(5S)-2-Methyl-5-prop-1-en-2-ylcyclohex-2-en-1-one (40)
Concentration
>=90-<=100
General Information
Version
6.11
Revision date
2025-12-27
Product name
L-Carvone
CAS No.
6485-40-1
Emergency telephone
+81 (0)3 4520 9637
Icons in SDS
Company Information
company name
Merck Ltd.
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H317
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning Warning
Hazard statements
H302 Harmful if swallowed. H317 May cause an allergic skin reaction. H317 May cause an allergic skin reaction.
Precautionary statements
P261 Avoid breathing mist or vapours. P264 Wash skin thoroughly after handling. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves. P261 Avoid breathing mist or vapours. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water.
Response
P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P302 + P352 IF ON SKIN: Wash with plenty of water. Reduced Labelling (<= 125 ml)
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 4 H302: Harmful if swallowed. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction.